Diabetic Foot Infections
Empirical Antibiotic Management based on Texas wound classification [Pennine Acute Trust; 2007]
Gr |
Clinical Criteria |
culture
specimen |
OPD option |
1st line empirical choice |
Penicillin-
allergy |
Usual
duration |
1 |
superf.;
eryth./warmth
<=2cm beyond
ulcer edges,
no swelling,
no lymphangitis
no sys. effects |
swab only
if pussy, or
initial Tx
failure |
Flu1gQds
+Amo500Tds
+/-Met400Tds; or:
Aug625Tds |
Flu1gQds[IV]
+Amo500Tds[IV]
+/-Met400Tds |
Cla500BdIV, or
Ery500Qds
+/-Met400Tds |
1-2w |
2 |
tend./caps., or
eryth./warmth
>2cm beyond
ulcer edges, or
lymphangitis, or
necrosis, or
sys. effects |
soft tissue Bx
(neuropathic
ulcers); swabs
(inflamed ulcer margins);
BC if
sys. effects |
Cli300Qds [!C.diff]
+Cip500Bd; or:
Aug625Tds |
Flu1-2gQdsIV
+Amo1gQdsIV
+Genta7mg/kgIBW;
switch to oral:
Flu1gQds
+Amo500Tds
+Cip500Bd
+/-Met400Tds |
Cli600QdsIV
+Gen7mg/kgIBWOd;
switch to oral:
Cli300Qds
+Cip500Bd |
2-4w
(IV:>=3-5d) |
3 |
penetrating ulcer;
involving
bone/joint |
BC if
sys. effects;
Bone Bx if poss;
deep soft tissue Bx;
[deep soft tissue
swabs: of limitied value] |
Cli450Qds [!C.diff]
+Cip750Bd; or:
Aug625Tds |
Flu2gIVQds
+Amo1gIVTds
+Gen7mg/kgOdIBW
+/-Met500IVTds;
switch to oral:
Flu1gQds
+Amo1gTds
+Cip750Bd
+/-Met400Tds |
Cli600QdsIV
+Gen7mg/kgIBWOd;
switch to oral:
Cli450Qds
+Cip750Bd |
6w
(IV:>=3-5d) |
Flu: QDS: Flucloxacillin: [elderly/intolerant:500mg-]1-2gQDS
Amo: TDS: Amoxicillin: 500tdsPO | 500-1000tdsIV
Aug: TDS: Augmentin: 625tdsPO
Cli: QDS: Clindamycin: 300-450qdsPO | 600qdsIV
Cip: BD: Ciprofloxacin: 500-750bdPO
Met: TDS: Metronidazole: 400tdsPO | 500tdsIV
Cla: BD: Clarithromycin: 500bdIV
Ery: QDS: Erythromycin: 500qdsPO
Vascular Doppler
|